Overview We are a commercial stage biotechnology company dedicated to the advancement regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Our platforms, therapies and products include the following: Our subsidiary, Creative Medical Technologies, Inc. (CMT), was originally created to monetize U.S. Patent No. 8,372,797 and related intellectual property related to the treatment of erectile dysfunction (ED), which it acquired in February 2016. Su...
Q2 FY2026 — expected 2026-07-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-20 | 2025-12-31 | 0001477932-26-001517 | EDGAR | 43K words |
| 2025-03-14 | 2024-12-31 | 0001477932-25-001736 | EDGAR | — |
| 2024-03-22 | 2023-12-31 | 0001477932-24-001431 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001477932-23-002123 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001477932-22-001741 | EDGAR | — |
| 2021-03-17 | 2020-12-31 | 0001477932-21-001495 | EDGAR | — |
| 2020-04-06 | 2019-12-31 | 0001104659-20-043660 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001144204-19-017462 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001144204-18-017967 | EDGAR | — |
| 2017-02-13 | 2016-12-31 | 0001144204-17-007873 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001477932-25-007978 | EDGAR | 14K words |
| 2025-08-08 | 2025-06-30 | 0001477932-25-005614 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001477932-25-003498 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001477932-24-006991 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001477932-24-004635 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001477932-24-002695 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001477932-23-008458 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001477932-23-005935 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001477932-23-003347 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001477932-22-008323 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001477932-22-005931 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001477932-22-003286 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-31 | 0001477932-25-009277 | EDGAR | 1K words |
| 2025-12-19 | 0001477932-25-009094 | EDGAR | — |
| 2025-11-12 | 0001477932-25-008027 | EDGAR | — |
| 2025-10-31 | 0001477932-25-007849 | EDGAR | — |
| 2025-05-06 | 0001477932-25-003370 | EDGAR | — |
| 2025-04-11 | 0001477932-25-002645 | EDGAR | — |
| 2025-03-14 | 0001477932-25-001737 | EDGAR | — |
| 2025-03-07 | 0001477932-25-001537 | EDGAR | — |
| 2024-12-26 | 0001477932-24-008314 | EDGAR | — |
| 2024-10-23 | 0001477932-24-006644 | EDGAR | — |
206 total filings indexed. 174 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001187953 |
| Ticker | CELZ |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
| Website | https://www.creativemedicaltechnology.com |
| Listed | 2009-04-30 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report